GE Healthcare Technologies Inc
NASDAQ:GEHC
Cash Flow Statement
Cash Flow Statement
GE Healthcare Technologies Inc
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
1 980
|
1 958
|
1 949
|
2 332
|
1 877
|
1 765
|
1 618
|
1 623
|
1 625
|
1 732
|
2 050
|
2 250
|
2 315
|
2 290
|
2 154
|
|
| Depreciation & Amortization |
625
|
630
|
633
|
790
|
630
|
623
|
610
|
601
|
594
|
584
|
580
|
568
|
567
|
572
|
578
|
|
| Stock-Based Compensation |
115
|
134
|
67
|
91
|
80
|
90
|
114
|
124
|
132
|
125
|
125
|
113
|
111
|
127
|
130
|
|
| Other Non-Cash Items |
(173)
|
376
|
477
|
472
|
598
|
182
|
151
|
136
|
166
|
59
|
(56)
|
(175)
|
(178)
|
(108)
|
42
|
|
| Cash Taxes Paid |
0
|
664
|
851
|
953
|
1 122
|
562
|
474
|
458
|
490
|
474
|
491
|
496
|
474
|
469
|
429
|
|
| Cash Interest Paid |
0
|
0
|
0
|
42
|
250
|
318
|
570
|
331
|
342
|
339
|
550
|
573
|
536
|
538
|
522
|
|
| Change in Working Capital |
(1 416)
|
(1 904)
|
(946)
|
(1 013)
|
(1 040)
|
(477)
|
(278)
|
(308)
|
(385)
|
(287)
|
(623)
|
(861)
|
(709)
|
(904)
|
(787)
|
|
| Cash from Operating Activities |
1 016
N/A
|
1 060
+4%
|
2 113
+99%
|
2 581
+22%
|
2 065
-20%
|
2 093
+1%
|
2 101
+0%
|
2 052
-2%
|
2 000
-3%
|
2 088
+4%
|
1 951
-7%
|
1 782
-9%
|
1 995
+12%
|
1 850
-7%
|
1 987
+7%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(292)
|
(306)
|
(310)
|
(453)
|
(364)
|
(370)
|
(387)
|
(389)
|
(383)
|
(393)
|
(401)
|
(408)
|
(430)
|
(450)
|
(482)
|
|
| Other Items |
(1 509)
|
(1 529)
|
(88)
|
(211)
|
(199)
|
(195)
|
(171)
|
(91)
|
(362)
|
(369)
|
(513)
|
(725)
|
(577)
|
(568)
|
(565)
|
|
| Cash from Investing Activities |
(1 801)
N/A
|
(1 835)
-2%
|
(398)
+78%
|
(664)
-67%
|
(563)
+15%
|
(565)
0%
|
(558)
+1%
|
(480)
+14%
|
(745)
-55%
|
(762)
-2%
|
(914)
-20%
|
(1 133)
-24%
|
(1 007)
+11%
|
(1 018)
-1%
|
(1 047)
-3%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
33
|
53
|
(46)
|
(173)
|
(163)
|
|
| Net Issuance of Debt |
(3)
|
4
|
8 204
|
10 189
|
10 187
|
10 199
|
1 139
|
(997)
|
(998)
|
(31)
|
(423)
|
(528)
|
965
|
(26)
|
968
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
(14)
|
(28)
|
(41)
|
(55)
|
(55)
|
(54)
|
(55)
|
(57)
|
(59)
|
(62)
|
(64)
|
|
| Other |
539
|
612
|
(9 026)
|
(10 338)
|
(10 269)
|
(9 786)
|
(1 576)
|
(252)
|
(81)
|
(142)
|
(128)
|
(174)
|
(148)
|
(106)
|
(124)
|
|
| Cash from Financing Activities |
536
N/A
|
616
+15%
|
(822)
N/A
|
(149)
+82%
|
(96)
+36%
|
385
N/A
|
(478)
N/A
|
(1 304)
-173%
|
(1 134)
+13%
|
(196)
+83%
|
(573)
-192%
|
(706)
-23%
|
712
N/A
|
(367)
N/A
|
617
N/A
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
(38)
|
(51)
|
(3)
|
5
|
9
|
3
|
(10)
|
(37)
|
(48)
|
22
|
(77)
|
(31)
|
48
|
(7)
|
66
|
|
| Net Change in Cash |
(287)
N/A
|
(210)
+27%
|
890
N/A
|
1 773
+99%
|
1 415
-20%
|
1 916
+35%
|
1 055
-45%
|
231
-78%
|
73
-68%
|
1 152
+1 478%
|
387
-66%
|
(88)
N/A
|
1 748
N/A
|
458
-74%
|
1 623
+254%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
724
N/A
|
754
+4%
|
1 803
+139%
|
2 128
+18%
|
1 701
-20%
|
1 723
+1%
|
1 714
-1%
|
1 663
-3%
|
1 617
-3%
|
1 695
+5%
|
1 550
-9%
|
1 374
-11%
|
1 565
+14%
|
1 400
-11%
|
1 505
+8%
|
|